Indian contribution toward biomedical research and development in COVID-19: A systematic review

COVID-19 pandemic led to an unprecedented collaborative effort among industry, academia, regulatory bodies, and governments with huge financial investments. Scientists and researchers from India also left no stone unturned to find therapeutic and preventive measures against COVID-19. Indian pharmace...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Hardeep, Kaur, Manpreet, Bhattacharyya, Anusuya, Prajapat, Manisha, Thota, Prasad, Sarma, Phulen, Kumar, Subodh, Kaur, Gurjeet, Sharma, Saurabh, Prakash, Ajay, Saifuddin, P. K., Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216129/
https://www.ncbi.nlm.nih.gov/pubmed/33976001
http://dx.doi.org/10.4103/ijp.ijp_168_21
Descripción
Sumario:COVID-19 pandemic led to an unprecedented collaborative effort among industry, academia, regulatory bodies, and governments with huge financial investments. Scientists and researchers from India also left no stone unturned to find therapeutic and preventive measures against COVID-19. Indian pharmaceutical companies are one of the leading manufacturers of vaccine in the world, are utilizing its capacity to its maximum, and are one among the forerunners in vaccine research against COVID-19 across the globe. In this systematic review, the information regarding contribution of Indian scientists toward COVID-19 research has been gathered from various news articles across Google platform apart from searching PubMed, WHO site, COVID-19 vaccine tracker, CTRI, clinicaltrials.gov, and websites of pharmaceutical companies. The article summarizes and highlights the various therapeutic and vaccine candidates, diagnostic kits, treatment agents, and technology being developed and tested by Indian researcher community against COVID-19.

Ejemplares similares